5/30
12:14 pm
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
5/30
11:43 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
5/30
08:06 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
3/28
08:06 am
imvt
Immunovant, Inc. (NASDAQ: IMVT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $50.00 price target on the stock.
Medium
Report
Immunovant, Inc. (NASDAQ: IMVT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $50.00 price target on the stock.
3/28
06:48 am
imvt
Rating for IMVT
Low
Report
Rating for IMVT
3/28
06:48 am
imvt
Rating for IMVT
Low
Report
Rating for IMVT
3/13
08:36 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
3/13
08:36 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT
3/13
08:36 am
imvt
Rating for IMVT
Medium
Report
Rating for IMVT